Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Diabetes Association (1997) Aspirin therapy in diabetes. Diabetes Care 20:1772–1773
Breddin HK, Krzywanek HJ, Althoff P, Schöffling K, Überla K, PARD (1986) Platelet aggregation as a risk factor in diabetes. Results of a prospective study. Klin Wochenschr 64:1042–1048
CAPRIE Steering Committee (1996) A randomised blinded trial of Clopidogrel versus Aspirin in Patients at Risc of Ischaemic Events (CAPRIE). Lancet 348:1329–1339
Chantelau E (2001) Does oral anticoagulation improve femoropedal graft patency in diabetic patients? Lessons from the Dutch BOA Study. VASA 58(Suppl) 47–49
Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci G, Ciabattoni G, Patrono C (1997) Diabetes mellitus, hypercholesterinemia and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 96:69–75
Dutch Bypass Oral anticoagulants or Aspirin Study Group (2000) Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery: a randomised trial. Lancet 355:346–351
ETDRS Investigators (1992) Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268:1292–1300
Ganda O, Arkin CF (1992) Hyperfibrinogenemia: an important risc factor for vascular complications in diabetes. Diabetes Care 15:1245–1250
Gosk-Bierska I, Adamiec R, Alexewicz P, Wysokinski WE (2002) Coagulation in diabetic and non-diabetic claudicants. Int Angiol 21:128–133
Jung F, Kiesewetter H, Körbel N, Wenzel E (1986) Microcirculatory and rheological alterations in type-I diabetes mellitus. Angio Archiv 12:27
Lawall H, Angelkort B (1999) Correlation between rheological parameters and erythrocyte velocity in nailfold capillaries in patients with diabetes mellitus. Clin Hemo Microcirc 20:41–47
Steering Committee of the Physicians Health Study Group (1989) Final report on the Aspirin component on the ongoing Physicians Health Study. N Engl J Med 321:129–135
Regensteiner JG, Hiatt WR (2002) Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med 112:49–57
Rendell M, Kimmel DB, Bamisedum O, O’Donnell ET, Fulmer J (1993) The health care status of the diabetic population as reflected by physician claims to a major insurer. Arch Intern Med 153(11):1360–1366
Trautner C, Haastert B, Spraul M, Giani G, Berger M (2001) Unchanged incidence of lower-limb amputations in a German setting 1990–1998. Diabetes Care 24:855–859
Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA (1995) Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes 44:890–894
Woelfle KD, Bruijnen H, Loeprecht H (2001) Infrapopliteal arterial occlusive disease in diabetics with critical foot ischaemia: The role of distal-origin bypass grafts. VASA 58(Suppl) 40–43
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
Diehm, C., Lawall, H. (2005). Gerinnungstherapie. In: Meinertz, T., Rösen, P., Ziegler, D., Schömig, A., Tschöpe, D. (eds) Diabetes und Herz. Steinkopff. https://doi.org/10.1007/3-7985-1531-X_24
Download citation
DOI: https://doi.org/10.1007/3-7985-1531-X_24
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1382-2
Online ISBN: 978-3-7985-1531-4
eBook Packages: Medicine (German Language)